Daily Aspirin and Cancer Mortality

LISA SCHULMEISTER, RN, MN, APRN-BC, OCN, FAAN
Tuesday, September 04, 2012
Talk about this article with nurses and others in the oncology community in the General Discussions Oncology Nursing News discussion group.

Daily aspirin usage is associated with a lower overall cancer mortality, but this association may be smaller than what has been reported in the literature and conveyed in the media.

Eric Jacobs, PhD, and colleagues examined the association between reported daily aspirin use and overall cancer mortality among 100,139 men and women with no history of cancer who participated in the Cancer Prevention Study II Nutrition Cohort. The researchers sent follow-up questionnaires to determine if the study participants took aspirin and found that among 5,138 participants who died from cancer, daily aspirin usage was linked with a slightly lower cancer mortality. However, the estimated reduced risk of 16% observed in this study was lower than the 37% reduction observed in prior randomized trials of aspirin use as a preventive measure for vascular events. These studies also found a 15% reduction in cancer mortality during the ten-year follow-up time periods. Consequently, it appears that aspirin does indeed reduce cancer mortality; however, risk reduction is likely lower than previously believed.

The researchers noted that a major limitation of the study was that it was an observational study and not a randomized trial, so confounding variables could have impacted their findings. Also, prior to recommending prophylactic aspirin use, the risks and benefits of aspirin use for each individual needs to be considered. For some, the potential risks (e.g. bleeding, etc.) will outweigh the potential benefit.


Reference

Jacobs EJ, Newton CC, Gapstur SM, Thum MJ. Daily aspirin use and cancer mortality in a large US cohort. J Natl Cancer Inst. 2012; 104(16): 1208-1217.


Talk about this article with nurses and others in the oncology community in the General Discussions Oncology Nursing News discussion group.
Lisa Schulmeister, MN, RN, ACNS-BC, FAAN
 
Blog Info
Lisa Schulmeister, MN, RN, ACNS-BC, FAAN is an oncology nursing consultant and editor-in-chief of Oncology Nursing News.
Author Bio
Lisa Schulmeister, MN, RN, ACNS-BC, FAAN, is the Editor-in-Chief for OncLive Nursing. She is an oncology nursing consultant and adjunct assistant professor of nursing at Louisiana State Health Sciences Center in New Orleans, LA. She provides continuing nursing education to nurses across the Unites States, is active in several professional nursing organizations, and is intrigued by the many ways nurses use technology to communicate.
 
 
External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
OncNurse Resources

Blogs
Continuing Education
Discussions
Web Exclusives


About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2017
Intellisphere, LLC. All Rights Reserved.